Press release

Invitation to presentation of the Q1 report 2023

May 2, 2023

Oncopeptides AB (publ) a biotech company focused on research, development, and commercialization of therapies for difficult-to-treat hematological diseases, will publish the report for the first quarter 2023 at 08:00 (CET) on May 4.

Investors, financial analysts, and media are invited to participate in a webcast and a following QnA session on May 4 at 09:00 (CET). The presentation will be hosted by Monica Shaw, CEO, together with Holger Lembrér, CFO, and will be held in English. It will be published on the website of Oncopeptides in conjunction with the start of the presentation.

Information for participants

If you wish to participate in the webcast, please use the link below. Through the webcast you will have opportunities to ask written questions to the company´s leadership.
https://ir.financialhearings.com/oncopeptides-q1-2023

If you wish to participate via teleconference, please register on the link below. After the registration you will be provided with a phone number and a conference ID to access the conference. You can ask questions to the leadership verbally via the teleconference. 
https://conference.financialhearings.com/teleconference/?id=200728